Charles River Laboratories International Inc. Common Stock (CRL)

About CRL

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of…

Sector

Health Care

Industry

Biotechnology: Commercial Physical & Biological Resarch

Employees

18,300

Website

www.criver.com/

Fundamentals

1-day range

$289.6$294.89

Market cap

$12.79B

P/E (trailing)

—

P/E (forward)

22.98

EPS (trailing)

$-4.85

Dividend yield

—

Beta

1.42

Avg. volume

890.8K

Forecasts

14 analyst ratings

Charles River Laboratories International Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• CRL

  Charles River Laboratories International Inc. Common Stock

  $291.74

  ▼ 1.58%
  Market cap $12.79BP/E —
  $144.26$303.31
• ICLR

  ICON plc Ordinary Shares

  $169.84

  ▲ 0.07%
  Market cap $12.34BP/E 183.55
  $66.57$203.91
• MEDP

  Medpace Holdings Inc. Common Stock

  $599.99

  ▼ 1.89%
  Market cap $16.33BP/E 33.13
  $373$677.9
• INCY

  Incyte Corp. Common Stock

  $124.39

  ▼ 2.63%
  Market cap $24.00BP/E 15.14
  $81.09$132.6
• ABSI

  Absci Corporation Common Stock

  $8.72

  ▼ 7.43%
  Market cap $1.29BP/E —
  $2.24$12.06
• MXCT

  MaxCyte Inc. Common Stock

  $1.22

  ▼ 4.69%
  Market cap $118.91MP/E —
• ONMD

  OneMedNet Corp Class A Common Stock

  $0.5801

  ▼ 0.84%
  Market cap $37.18MP/E —
  $0.49$4.22

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Charles River Laboratories International (CRL) Price Target Increased by 17.31% to 274.25
  Fintel · 8/28/2026
• Here's How Much $100 Invested In Charles River 15 Years Ago Would Be Worth Today
  Benzinga · 8/25/2026
• Tracking John Rogers' Ariel Investments Portfolio - Q2 2026 Update
  SeekingAlpha · 8/24/2026
• Does Charles River (CRL)–Medigen Vaccine Work Sharpen the Case for Its Complex Biologics Edge?
  Yahoo · 8/22/2026
• Why Is Charles River Laboratories International (CRL) Pushing Deeper Into Vaccine Development?
  Yahoo · 8/22/2026
• CRL Jumps 33.3% in the Past Month: Can This Strong Rally Keep Running?
  Yahoo · 8/21/2026
• Are Options Traders Betting on a Big Move in Charles River Stock?
  Yahoo · 8/21/2026
• Charles River Gains 88.6% in a Year: What's Driving the Rally?
  Yahoo · 8/21/2026

• James C. Foster · August 25, 2026 · Option Exercise

  12.4K @ $208.44
• James C. Foster · August 25, 2026 · Option Exercise

  21.1K @ $194.12
• James C. Foster · August 25, 2026 · Sale

  33.6K @ $300
• Birgit Girshick · August 11, 2026 · Option Exercise

  6.5K @ $179.66
• Birgit Girshick · August 11, 2026 · Sale

  6.5K @ $279.9
• Shannon M. Parisotto · August 11, 2026 · Option Exercise

  3.7K @ $179.66
• Shannon M. Parisotto · August 11, 2026 · Sale

  3.7K @ $279.66
• Joseph W. LaPlume · August 10, 2026 · Gift

  257
• James C. Foster · August 10, 2026 · Option Exercise

  28.7K @ $179.66
• James C. Foster · August 10, 2026 · Sale

  28.7K @ $275
• Michael Gunnar Knell · August 6, 2026 · Option Exercise

  736 @ $208.44
• Michael Gunnar Knell · August 6, 2026 · Option Exercise

  1.2K @ $194.12
• Michael Gunnar Knell · August 6, 2026 · Option Exercise

  404 @ $179.66
• Michael Gunnar Knell · August 6, 2026 · Sale

  736 @ $258.53
• Michael Gunnar Knell · August 6, 2026 · Sale

  1.2K @ $258.53

Institutional Ownership

March 31, 2026

Total shares held

54.48M

Total value held

$8.91B

Institutional holders

550